UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis

Lab on a chip, 2014-01, Vol.14 (1), p.1775-1784

2014

Volltextzugriff (PDF)

Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids

PloS one, 2022-05, Vol.17 (5), p.e0267882-e0267882

2022

Volltextzugriff (PDF)

A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma

Cancer research (Chicago, Ill.), 2022-08, Vol.82 (15), p.2761-2776

2022

Volltextzugriff (PDF)

Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions

Gastroenterology (New York, N.Y. 1943), 2014-03, Vol.146 (3), p.647-651

2014

Volltextzugriff (PDF)

anti-EGFR capture mitigates EMT- and chemoresistance-associated heterogeneity in a resistance-profiling CTC platform

Analytical biochemistry, 2019-07, Vol.577, p.26-33

2019

Volltextzugriff (PDF)

Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling

Development (Cambridge), 2023-01, Vol.150 (2)

2023

Volltextzugriff (PDF)

Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential

Cancer discovery, 2023-08, Vol.13 (8), p.1844-1861

2023

Volltextzugriff (PDF)

Abstract PR-15: Identifying synergistic combinations with KRAS inhibition in PDAC

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (17_Supplement_2), p.PR-15-PR-15

2024

Volltextzugriff (PDF)

Abstract C057: Delineating tissue-specific oncogene selection with autochthonous CRISPR activation screening

Cancer research (Chicago, Ill.), 2024-01, Vol.84 (2_Supplement), p.C057-C057

2024

Volltextzugriff (PDF)

Abstract C55: Mapping the pharmacotranscriptomic landscape of pancreatic circulating tumor cell organoids

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (24_Supplement), p.C55-C55

2019

Volltextzugriff (PDF)

Abstract 1506: APOBEC3A a causative agent in cancer-related chromosomal instability and STING driven metastasis

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1506-1506

2022

Volltextzugriff (PDF)

Abstract PR-13: Disruption of sulfatide metabolism by targeting UGT8 is an actionable metabolic vulnerability for pancreatic cancer early interception

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (17_Supplement_2), p.PR-13-PR-13

2024

Volltextzugriff (PDF)

Abstract 3: In vivo CRISPR activation screening identifies tissue-specific oncogene selection

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3-3

2023

Volltextzugriff (PDF)

Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT

Biomicrofluidics, 2016-11, Vol.10 (6), p.064109-064109

2016

Volltextzugriff (PDF)

Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas

Gut, 2024-09, p.gutjnl-2024-332412

2024

Volltextzugriff (PDF)

Abstract 636: Role of Apobec3a in pancreatitis and inflammation triggered carcinogenesis

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.636-636

2023

Volltextzugriff (PDF)

Abstract B058: Mutant GNAS drives glycolytic dependency in intraductal papillary mucinous neoplasms of the pancreas

Cancer research (Chicago, Ill.), 2024-01, Vol.84 (2_Supplement), p.B058-B058

2024

Volltextzugriff (PDF)

Abstract 918: Development of a platform for programmable in vivo oncogene activation and screening using CRISPRa technology

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.918-918

2022

Volltextzugriff (PDF)

Abstract 446: Integrated spatial transcriptomics and lipidomics analyses of intraductal papillary mucinous neoplasm identifies enrichment of long chain sulfatide as an early metabolic alteration

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.446-446

2024

Volltextzugriff (PDF)

The effect of phenotypic heterogeneity on pancreatic circulating tumor cell capture and tumor spheroids

Thege, Fredrik Ivar

2017

Volltextzugriff (PDF)

Automated electrorotation shows electrokinetic separation of pancreaticcancer cells is robust to acquired chemotherapy resistance, serum starvation, andEMT

Biomicrofluidics, 2016-11, Vol.10 (6)

2016

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(20)
Dissertationen
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis

Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids

A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma

Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions

anti-EGFR capture mitigates EMT- and chemoresistance-associated heterogeneity in a resistance-profiling CTC platform

Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling

Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential

Abstract PR-15: Identifying synergistic combinations with KRAS inhibition in PDAC

Abstract C057: Delineating tissue-specific oncogene selection with autochthonous CRISPR activation screening

Abstract C55: Mapping the pharmacotranscriptomic landscape of pancreatic circulating tumor cell organoids

Abstract 1506: APOBEC3A a causative agent in cancer-related chromosomal instability and STING driven metastasis

Abstract PR-13: Disruption of sulfatide metabolism by targeting UGT8 is an actionable metabolic vulnerability for pancreatic cancer early interception

Abstract 3: In vivo CRISPR activation screening identifies tissue-specific oncogene selection

Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT

Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas

Abstract 636: Role of Apobec3a in pancreatitis and inflammation triggered carcinogenesis

Abstract B058: Mutant GNAS drives glycolytic dependency in intraductal papillary mucinous neoplasms of the pancreas

Abstract 918: Development of a platform for programmable in vivo oncogene activation and screening using CRISPRa technology

Abstract 446: Integrated spatial transcriptomics and lipidomics analyses of intraductal papillary mucinous neoplasm identifies enrichment of long chain sulfatide as an early metabolic alteration

The effect of phenotypic heterogeneity on pancreatic circulating tumor cell capture and tumor spheroids

Automated electrorotation shows electrokinetic separation of pancreaticcancer cells is robust to acquired chemotherapy resistance, serum starvation, andEMT

Aktive Filter

Suchergebnisse filtern